JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOM
Should you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM).
Johnson & Johnson vs. Its Competitors
Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.
Intuitive Surgical has a net margin of 28.41% compared to Johnson & Johnson's net margin of 24.42%. Johnson & Johnson's return on equity of 33.46% beat Intuitive Surgical's return on equity.
Intuitive Surgical presently has a consensus price target of $588.95, indicating a potential upside of 8.32%. Johnson & Johnson has a consensus price target of $170.88, indicating a potential upside of 9.61%. Given Johnson & Johnson's higher probable upside, analysts plainly believe Johnson & Johnson is more favorable than Intuitive Surgical.
In the previous week, Johnson & Johnson had 37 more articles in the media than Intuitive Surgical. MarketBeat recorded 88 mentions for Johnson & Johnson and 51 mentions for Intuitive Surgical. Johnson & Johnson's average media sentiment score of 1.52 beat Intuitive Surgical's score of 1.42 indicating that Johnson & Johnson is being referred to more favorably in the news media.
83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 69.6% of Johnson & Johnson shares are owned by institutional investors. 0.7% of Intuitive Surgical shares are owned by company insiders. Comparatively, 0.2% of Johnson & Johnson shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Intuitive Surgical has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, Johnson & Johnson has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500.
Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Summary
Johnson & Johnson beats Intuitive Surgical on 9 of the 17 factors compared between the two stocks.
Get Johnson & Johnson News Delivered to You Automatically
Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Johnson & Johnson Competitors List
Related Companies and Tools
This page (NYSE:JNJ) was last updated on 7/5/2025 by MarketBeat.com Staff